What are the leading causes of death in patients with chronic kidney disease who are underdialyzed?

Causes of Death in Underdialyzed Chronic Kidney Disease Patients

Cardiovascular disease is overwhelmingly the leading cause of death in underdialyzed CKD patients, accounting for approximately 40-66% of all deaths, with infection being the second most common cause at 16-31%. 1

Primary Causes of Death

Cardiovascular Disease (Leading Cause)

The enormous cardiovascular disease burden in underdialyzed CKD patients manifests as:

• Coronary heart disease and heart failure (most prevalent at 37.3% and 14.5% respectively) 2
• Cerebrovascular disease/stroke (19.6% of deaths in some cohorts) 3
• Sudden cardiac death - the single largest cause within the cardiovascular category 4
• Acute myocardial infarction 2

The cardiovascular mortality rate in dialysis patients remains unacceptably high at 17-20% annually in the United States, compared to less than 10% in Japan 1. This reflects the "enormous risk for cardiovascular disease in patients with CKD stage 5 compared with patients with normal renal function" 1.

Infection (Second Leading Cause)

Infections account for 16.5-42.6% of deaths, with the highest rates seen in patients with:

• Diabetic nephropathy (42.6%) 5
• Systemic vasculitis (71.4%) 5
• Lower serum albumin and higher CRP levels 3

Other Significant Causes

• Multi-organ failure
• Cerebrovascular accidents (3.4% prevalence, but 19.6% of deaths) 2, 3
• Complications of inadequate dialysis itself 1

Why Underdialysis Increases Mortality

The pathophysiology involves multiple interconnected mechanisms 1:

Uremic Toxin Accumulation

• Retention of large molecular weight solutes poorly removed by inadequate diffusion/convection
• Protein-bound toxins that accumulate despite dialysis
• Drug metabolites that concentrate in underdialyzed patients
• Non-uremia-associated toxins including historical examples like aluminum toxicity

Cardiovascular Stress Mechanisms

• Physiological stress from intermittent dialysis schedules causing fluctuations in fluid balance and solute concentrations
• Volume overload leading to left ventricular hypertrophy (present in 75% of patients starting hemodialysis) 6
• Inflammatory state from contaminated dialysate or soft-tissue calcium deposits 1
• Loss of residual kidney function - strongly associated with survival in both HD and PD patients 1

Metabolic Derangements

• Hyperkalemia (OR 2.19 for cardiovascular death) 3
• Hyperphosphatemia 7
• Elevated LDL-cholesterol (OR 1.37 for cardiovascular death) 3
• Hypoalbuminemia (marker of malnutrition-inflammation-atherosclerosis syndrome) 8

High-Risk Patient Profiles

Patients at highest risk for death from underdialysis include:

1. First-year dialysis patients - mortality rate of 56.5 per 100 patient-years 9
2. Diabetic nephropathy patients - higher infection-related mortality 5
3. Elderly patients (>75 years) - though relative risk of modifiable factors decreases with age 10
4. Those with established comorbidities:
   • Hypertension (100% prevalence in documented cases) 3
   • Diabetes mellitus (100% in documented cases) 3
   • Pre-existing cardiovascular disease 4
   • Cerebrovascular disease 5

Critical Clinical Pitfalls

The most dangerous assumption is that increasing dialysis dose alone will solve the mortality problem. The HEMO Study demonstrated that higher dialysis doses did not reduce mortality 1, redirecting attention to:

• Volume control inadequacy - more critical than small-solute clearance
• Loss of hormones normally produced by the kidney - not responsive to dialysis 1
• Established comorbidities at dialysis initiation - already present left ventricular hypertrophy and heart failure cannot be reversed by adequate dialysis alone 6

Patients with CKD are more likely to die of cardiovascular causes than progress to ESRD - mortality at 96 months exceeds 50% in patients with baseline creatinine ≥2.5 mg/dL, with most dying from ischemic heart disease or cerebrovascular disease rather than kidney disease 6.

Modifiable Risk Factors

The attributable mortality burden from modifiable factors is highest in younger patients (PAF 44.3% in ages 18-54 vs. 22.6% in ≥85 years) 10:

• Suboptimal LDL-C control (12.0% PAF in younger patients) 10
• Blood pressure control - target systolic <120 mmHg when tolerable 11
• Volume status - high volume load is an independent risk factor 7
• Anemia - independent risk factor for death 7
• Malnutrition (low albumin, low BMI) 3, 8

The consistent maintenance of euvolemia is a cornerstone of treatment and may be more important than dialysis adequacy itself 4.